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Acyl-CoA synthases are important for lipid synthesis
and breakdown, generation of signaling molecules,
and lipid modification of proteins, highlighting
the challenge of understanding metabolic path-
ways within intact organisms. From a C. elegans
mutagenesis screen, we found that loss of ACS-3,
a long-chain acyl-CoA synthase, causes enhanced
intestinal lipid uptake, de novo fat synthesis, and
accumulation of enlarged, neutral lipid-rich intestinal
depots. Here, we show that ACS-3 functions in seam
cells, epidermal cells anatomically distinct from sites
of fat uptake and storage, and that acs-3 mutant
phenotypes require the nuclear hormone receptor
NHR-25, a key regulator of C. elegans molting. Our
findings suggest that ACS-3-derived long-chain
fatty acyl-CoAs, perhaps incorporated into com-
plex ligands such as phosphoinositides, modulate
NHR-25 function, which in turn regulates an endo-
crine program of lipid uptake and synthesis. These
results reveal a link between acyl-CoA synthase
function and an NR5A family nuclear receptor in
C. elegans.
INTRODUCTION
The ability to store nutrients, primarily in the form of triacylglycer-
ides, is necessary to provide energy during periods when energy
demands exceed caloric intake; however, excessive diversion of
nutrients for storage can impair growth and reduce reproductive
fitness and is associated with adverse health effects (Guh et al.,
2009; Reeves et al., 2007). Numerous studies in organisms
ranging from bacteria to humans have identified enzymatic
components of metabolism as well as its neural and endocrine398 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inregulators. Although many of these components have already
been characterized at the biochemical and structural levels,
understanding the precise mechanisms by which metabolic
activities of various tissues are coordinated and how dysregula-
tion of these processes may result in aberrant metabolic regula-
tion remains a significant challenge.
One complexity of metabolism is that many enzyme families
are composed of multiple and seemingly redundant members.
For instance, at least 26 known or predicted acyl-CoA synthase
(ACS) genes are found in the human genome (Watkins et al.,
2007). The ACS family of enzymes catalyzes conversation of
free fatty acids to acyl-CoA derivates. Although the ACS
enzymes have been classified based on their substrate chain
length preference into very-long-chain, long-chain, medium-
chain, and short-chain families, the precise physiological roles
of most of these enzymes are unknown. Another complexity of
metabolism is that the same metabolic intermediates can,
depending on the pathway into which they are channeled, have
vastly different fates. For instance, acyl-CoAs can be substrates
for fat breakdown throughmitochondrial or peroxisomal b oxida-
tion, or alternatively, they may be substrates for synthesis path-
ways, generating triglycerides for storage or structural compo-
nents of membranes such as phospholipids (Coleman et al.,
2002). Additionally, acyl-CoAs serve as substrates for lipid modi-
fication of proteins and function as signaling molecules either
on their own or as components of more complex molecules,
such as phosphoinositols and sphingolipids (Bartke and Han-
nun, 2009; Black and DiRusso, 2007; Faergeman and Knudsen,
1997; Payrastre et al., 2001). Thus, the consequences of misre-
gulation of an individual ACS are quite difficult to predict even
when the biochemical activity of that ACS is known.
C. elegans is an emergingmodel for the study of metabolism in
the context of intact animals (Jones and Ashrafi, 2009; Mullaney
and Ashrafi, 2009; Watts, 2009). Like most free-living organisms,
C. elegans normally live in environments where food availability
is dynamic. Thus, they are able to sense nutrient levels and
coordinate their behavioral, physiological, and metabolic
responses accordingly. Despite obvious differences, manyc.
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served in C. elegans. These include fat and sugar uptake, trans-
port, breakdown, and synthesis pathways; transcriptional regu-
lators such as nuclear hormone receptors (NHRs) and sterol
response element binding protein (SREBP); energy sensing
mechanisms such as AMP-activated kinase and target of rapa-
mycin (TOR) kinase; as well as endocrine regulators such as
insulin (Ashrafi, 2007). The genetic tractability of C. elegans
allows for the study of metabolic regulation through use of
suppressor and enhancer screens to identify components of
complex pathways (Hodgkin, 2005).
Thus far, of the more than 20 ACSs encoded by the C. elegans
genome, phenotypes have been reported for only a few: loss-of-
function mutations in acs-20 and acs-22 cause defective cuticle
formation (Kage-Nakadai et al., 2010), while acs-4 and acs-5 are
required for serotonin-induced fat reduction (Srinivasan et al.,
2008). In this study, we show that reduction of function of acs-
3, encoding a long-chain ACS, causes altered patterns of neutral
lipid deposition and increased rates of fatty acid uptake and de
novo synthesis. We show that acs-3 function in epidermal
seam cells is sufficient for restoration of wild-type (WT) lipid
deposition to acs-3 mutants. Since seam cells are anatomically
distinct from sites of fat uptake, de novo synthesis, and storage,
our findings suggest that acs-3 must exert its effects on whole-
animal fat metabolism through mediators that can act cell
nonautonomously. To uncover these mechanisms, we con-
ducted suppressor screens and found that the acs-3 mutant
phenotypes could be reverted to WT by additional mutations in
metabolic enzymes that consume acyl-CoAs and by nhr-25,
the only C. elegans member of the NR5A family of NHRs that
includes mammalian steroidogenic factor-1 (SF-1) and liver
receptor homolog-1 (LRH-1). Our genetic and biochemical anal-
yses suggest a model whereby ACS-3-generated products ulti-
mately modulate the function of NHR-25, which in turn could
regulate an endocrine program of fat uptake and synthesis.
RESULTS
ft5Mutants Exhibit Altered Fat Storage
To identify genes important in the regulation of fat storage in
C. elegans, we performed an unbiased mutagenesis screen
and isolated mutants with elevated staining of Nile Red, a
solvatochromatic vital dye that has been used in mammalian,
Drosophila, C. elegans, and other experimental systems to iden-
tify and characterize metabolic pathways involved in fat metab-
olism (Chen et al., 2009; Flynn et al., 2009; Fowler and Green-
span, 1985; Jones et al., 2008; McKay et al., 2003; Siloto et al.,
2009; Suh et al., 2007; Van Gilst et al., 2005). We found a reces-
sive mutant, ft5, that exhibited dramatically elevated staining but
developed at nearly the same rate as WT animals (Figure 1A).
To verify that the phenotype was not specific to the Nile Red
dye, we grew animals on bacteria containing BODIPY-labeled
fatty acid and observed a similar increase in staining intensity
(Figure 1A). Additionally, ft5 mutants exhibited large intestinal
granules not seen in WT animals. These enlarged granules
were visible with DIC microscopy (Figure 1B), stained with
BODIPY-labeled fatty acids (Figure 1B), and stained in fixed
animals with Sudan Black (Figure 1F), a diazo dye used for
detection of lipids (Greer et al., 2008). They were also encircledCellby a GFP reporter fused to C. elegans ATGL, a lipase that in
mammalian and Drosophila cells is important for hydrolysis of
triglycerides from lipid droplets (Gro¨nke et al., 2005; Zimmer-
mann et al., 2004) (Figure 1C). Similar morphological and ATGL
localization phenotypes were recently described in C. elegans
with increased fat accumulation due to disrupted peroxisomal
fat breakdown (Zhang et al., 2010).
Unlike BODIPY-labeled fatty acids or dyes used for detection
of lipids in fixed samples, an advantage of Nile Red is that its
spectral properties are exquisitely sensitive to the polarity of
the environment in which it resides (Fowler and Greenspan,
1985; Greenspan and Fowler, 1985). For instance, in relatively
polar phospholipid-rich environments, Nile Red’s fluorescence
emission spectrum exhibits a peak intensity at 629 nm, while in
relatively neutral lipid-rich environments such as triglyceride-
rich fat droplets, it emits yellow-gold fluorescence characterized
by an intensity peak at 576 nm (Greenspan and Fowler, 1985).
Because of this property, Nile Red has been used in mammalian
systems to distinguish between various particles that stain with
lipophilic dyes to specifically define neutral lipid-rich deposits
(Fowler and Greenspan, 1985). Nevertheless, use of Nile Red
as a vital dye to interrogate C. elegans fat storage has recently
been criticized, in part due to the claim that this dye fails to stain
lipid depots in tissues such as the skin-like hypodermis or in
developing embryos within the hermaphrodite gonad (Brooks
et al., 2009; O’Rourke et al., 2009). We found that by simply
increasing the concentration of Nile Red fed to living animals, it
was possible to visualize yellow fluorescence in the enlarged
droplets seen in ft5mutants (Figure 1D) as well as in hypodermis
and developing embryos (data not shown). Moreover, the yellow
fluorescent granules emitted with peak intensity between 570
and 580 nm, indicative of an environment rich in neutral lipids
(Figure 1E).
The ft5Mutation Maps to a Seam-Cell-Expressed
Acyl-CoA Synthase
To identify the causative mutation in ft5, we performed positional
cloning followed by sequence analysis and found aG-to-Amuta-
tion in the T08B1.6 gene. This mutation results in a glycine to glu-
tamic acid substitution at amino acid 118 of the predicted protein
(Table 1). T08B1.6 encodes a predicted long-chain fatty ACS,
which we named acs-3.
To begin characterization of acs-3, we first generated trans-
genic animals carrying 2.5 kb of the acs-3 upstream regula-
tory sequence fused to a GFP reporter. GFP expression was
observed, beginning during embryogenesis and continuing
through adulthood. From larval stage L1 to L4, expression
appeared restricted to epidermal seam cells, the excretory cell,
vulva cells, and a subset of unidentified cells in the head and
tail (Figures 2A, 2B, and S1). In addition to prominent seam
cell expression, adult animals also exhibited moderate intesti-
nal GFP expression. Tissue expression patterns observed by
the promoter-reporter fusion were recapitulated by transgenic
animals in which full-length acs-3 cDNA was tagged at the
C terminus with GFP and driven by the same 2.5 kb upstream
regulatory elements (Figure S1). Nile Red fat staining of these
transgenic animals was restored to near WT levels, indicating
that the 2.5 kb promoter is sufficient for regulation of lipid storage
(Figures 2F and 2G).Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc. 399
Figure 1. Mutation of acs-3, a Long-Chain
Acyl-CoA Synthase, Results in Altered Fat
Storage
(A–F) From a mutagenesis screen, we identified
a line, acs-3(ft5), that exhibits elevated staining
when fed bacteria labeled with both Nile Red
(50 nM) and BODIPY-labeled fatty acid (A). Further
analysis of acs-3(ft5) mutants revealed the pres-
ence of large refractile droplets visible using DIC
microscopy, which were not seen in WT animals.
These large droplets stain with BODIPY-labeled
fatty acid (B). The lipase ATGL, a lipid droplet-
associated protein, appears as rings associated
with the perimeter of these large droplets in acs-
3(ft5) mutant animals (C). When acs-3(ft5) mutant
animals are labeled with 5 mM (1003) Nile Red,
these droplets stain yellow-gold, while intestinal
cells of WT animals lack these large droplets (D).
To measure emission spectra, we utilized a spec-
tral confocal microscope, exciting with a 488 nm
laser and collecting emitted light at 5 nm intervals
between 500 and 660 nm. The emission peak for
an individual droplet is between 470 and 480 nm,
indicating that these large droplets contain neutral
lipids (E). When fixed and stained with the lipid dye
Sudan Black, these large droplets are clearly
labeled (F). In all panels, arrows indicate the posi-
tion of abnormally large lipid droplets. In (C), the
scale bar represents 5 mM, and N denotes the
position of an intestinal cell nucleus.
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could be sufficient for fat storage regulation, we expressed full-
length WT acs-3 using a variety of tissue-specific promoters in
acs-3(ft5) mutants. Expression of acs-3 in seam cells, using the
previously characterized wrt-2 and grd-10 seam-cell-specific
promoters (Aspo¨ck et al., 1999), was sufficient to almost fully
rescue the fat storage phenotype of acs-3(ft5) animals (Figures
2F and 2G). We attempted numerous injections of an intestinally
driven acs-3 construct, but they caused lethality in nearly
all instances. In one case, a single line carrying intestinally ex-
pressed acs-3 was generated; however, the transgenic animals
exhibited numerous phenotypes associated with sickness, such
as slow growth or growth arrest, small body size, and clear intes-
tine (data not shown). Expression of acs-3 specifically in body-
wall muscle, a tissue in which we never observed expression
with the acs-3 promoter, failed to alter excess Nile Red staining400 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc.of acs-3(ft5) animals (Figures 2F and 2G).
Taken together, these data indicated that
reconstitution of acs-3 in seam cells was
sufficient to confer WT fat staining to
acs-3(ft5) mutants, but expression at
similar or higher levels in another tissue
did not rescue the altered lipid storage
of these mutants.
Within the seam cells, expression of
full-length ACS-3 fused to GFP at the
C terminus driven by the rescuing 2.5 kb
promoter resulted in localization of the
fusion protein throughout the cytoplasm.
Expression of the same reporter fusiondriven by the seam-cell-specific promoterswrt-2 or grd-10, which
allowed for nearly full rescue of acs-3(ft5) fat storage phenotype,
resulted in clear localization of the reporter protein to the plasma
membrane of seam cells (Figures 2C and 2D). Based on its amino
acid sequence, the ACS-3 protein is not predicted to have any
transmembranedomains. Thus,ACS-3 is likely a cytosolic enzyme
that is localized to the inner leaflet of the plasma membrane of
seam cells, and the difference in subcellular localization using
the indicated promoters is likely a consequence of differences in
the extent of promoter activity. Consistent with this, there was no
obvious overlap between reporter fusions to ACS-3 and CLK-1,
a C. elegansmitochondrial protein (Felkai et al., 1999) (Figure S1).
Localization of ACS-3 to seam cells was unexpected, as these
cells have not been previously implicated in fat storage or
regulation. Seam cells are relatively poorly characterized cells
that are part of the skin-like epidermis of C. elegans. During
Table 1. Mutations Isolated
Allele Gene ID Gene Name Gene Function Locus Mutation
ft5 T08B1.6 acs-3 Acyl-CoA synthase V: 16.58 Gly118/ Glu
ft8 Y45F3A.3 acdh-11 Acyl-CoA dehydrogenase III: 3.73 Asp309/ Asn
ft12 Y45F3A.3 acdh-11 Acyl-CoA dehydrogenase III: 3.73 Ala244/ Thr
ft11 T08G2.3 acdh-10 Acyl-CoA dehydrogenase X: 24.09 Gly259/ Glu
ft14 F41H10.8 elo-6 Fatty acid elongase IV: 1.64 Gln205/ STOP
ft13 Y46E12BL.4 spsb-1 Unknown II: 24.58 Gly3/ Glu
Molecular identities of mutant alleles identified in this study. acs-3(ft5) was isolated from a screen for animals with altered Nile Red staining, while all
othermutants were isolated from an acs-3(ft5) suppressor screen by identifying animals that do not arrest on 110 mMLY294002. Each allele identified in
this screen also suppressed the fat storage phenotype of acs-3(ft5).
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go through multiple rounds of division whereby a subset of
daughter cells regenerates the seam cell population after each
division, while the remainder differentiate into epidermal, glial,
or neuronal cells (Sulston and Horvitz, 1977).
RecombinantACS-3ExhibitsAcyl-CoASynthaseActivity
In Vitro and Prefers Long-Chain Fatty Acid Substrates
To confirm the predicted function of ACS-3, we generated and
purified recombinant protein. Using an in vitro colorimetric assay,
we tested the activity of this recombinant ACS-3 protein along
with a commercially available Pseudomonas ACS as a positive
control. Pseudomonas ACS exhibited strong ACS activity and
could use a broad range of fatty acid chain lengths as substrate,
in accordance with previous findings (Hosaka et al., 1981; Knoll
et al., 1994) (Figure S2). Recombinant C. elegans ACS-3 also
exhibited ACS activity but was capable of activating a narrower
range of fatty acid chain lengths. 18-carbon fatty acid was the
preferred substrate chain length, but the enzyme exhibited
significant activity on 20- and 22-carbon fatty acids, as well
(Figure S2). These findings confirm the predicted long-chain fatty
acyl-CoA (LCFA-CoA) synthase function of ACS-3.
We next tested the activity of recombinant mutant ACS-3
protein in which we introduced the Glu118 to Gly mutation iden-
tified in acs-3(ft5) animals. Surprisingly, this protein exhibited
activity equivalent to WT protein (Figure S2). Thus, we asked
whether the Glu118 to Gly mutation disrupts other aspects of
ACS-3 function, such as its localization or expression pattern.
As assessed by the full-length GFP reporter, the mutant ACS-3
proteinmislocalized to the nucleus (Figure 2E). The incorrect traf-
ficking of themutant protein raised the possibility that themutant
phenotypemay arise from inappropriate ACS activity in the seam
cell nucleus. However, the recessive nature of the ft5 mutation,
coupled with the fact that acs-3(ft5) mutants can be rescued by
expression of theWTcDNA, indicated that themutant phenotype
corresponded to acs-3 loss of function rather than neomorphic
activity. Thus, the Glu118 to Gly mutation likely disrupts ACS-3
function by mislocalizing this enzyme to the nucleus.
Measures of Metabolic Parameters Demonstrate
that acs-3(ft5) Animals Exhibit Elevated Rates of Fatty
Acid Uptake and Increased Rates of De Novo Fatty
Acid Synthesis
To better understand the altered fat storage phenotype of acs-3
(ft5) animals, we assayed various behavioral and metabolicCellparameters of thesemutants.C. elegans intake nutrients through
pharyngeal pumping, the rate of which is subject to modulation
by food availability and food quality as well as experience of
starvation prior to food exposure (Avery and Horvitz, 1990; You
et al., 2008). We found that pumping rates in acs-3(ft5) and WT
animals were equivalent. Similarly, brood size and rates ofmove-
ment of acs-3(ft5) were indistinguishable from those of WT
animals (Figures 3B and 3C and data not shown). Finally, we
found that under conditions of full starvation, acs-3 mutants
tended to survive slightly longer than WT animals, although the
differences in overall survival rate were not statistically signifi-
cant (Figure S1).
The requirement of ACS enzymes for consumption of fatty
acids suggested defective b oxidation as a likely explanation
for the observed fat storage phenotype. To directly test this
hypothesis, we fed animals radiolabeled oleic acid and mea-
sured rates of production of labeled water, a byproduct of fat
oxidation. Surprisingly, acs-3(ft5) animals showed an increase
in b oxidation rate (Figure 3A). Since this assay is dependent
on uptake of radiolabeled oleic acid by whole animals, it raised
the possibility that the observed enhanced rate of labeled water
production could reflect increased rate of fatty acid absorption
rather than increased fat oxidation. To evaluate this possibility,
we adapted an assay for fatty acid uptake that has been previ-
ously utilized in yeast and mammalian cell culture-based exper-
iments (Jia et al., 2007; Li et al., 2005a; Schaffer and Lodish,
1994) as well as recently in C. elegans (Spanier et al., 2009).
We empirically determined conditions whereby feeding ani-
mals a short pulse of the fluorescently labeled fatty acid C1-
BODIPY 500/512 C12 allowed for comparison of rate of fatty
acid uptake. Based on this assay, acs-3(ft5) animals exhibited
a striking increase in uptake rate compared to WT animals
(Figure 3D). After uptake of a pulse of fluorescently labeled fatty
acids, the rate of diminishment of fluorescence was similar inWT
and mutant animals (data not shown), indicating that the
increased accumulation of labeled dietary fatty acids in acs-3
(ft5) animals reflected increased rate of fat uptake rather than
reduced efflux. Assuming that the assay conditions did not satu-
rate the capacity of b oxidation enzymes, the increased rate of
b oxidation of acs-3(ft5) mutants likely reflects increased rate
of labeled oleate uptake. Thus, when normalized to the rate of
fatty acid uptake, the rate of b oxidation of acs-3(ft5) animals
may be similar to that of WT animals.
Next, we assessed rates of de novo fatty acid synthesis.
acs-3(ft5) animals exhibited approximately 50% increased ratesMetabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc. 401
Figure 2. acs-3 Has a Limited Expression
Pattern, and Expression of acs-3 in Seam
Cells Rescues the Fat Storage Phenotype
(A–G) To examine the expression pattern of acs-3,
we fused 2.5 kb of upstream regulatory sequence
to GFP. This construct yields high expression in a
limited set of tissues. In L4 animals, strong expres-
sion is evident in seam cells, which are beginning
to fuse at this stage; the excretory cell (marked
Ex); and vulva (marked Vul); as well as in cells in
the head and tail (A). In an L2 animal, individual
seam cells are clearly visible (B). We also gener-
ated constructs driving the acs-3 cDNA fused to
GFP. We drove this construct with the previously
characterized seam cell promoters wrt-2 (C) and
grd-10 (D). With both constructs, ACS-3 is clearly
localized to the cell membrane (C and D). Whenwe
drove the acs-3(ft5) mutant cDNA, we observed
mislocalization of the protein to seam cell nuclei
(E). In (A)–(E), arrows mark the position of seam
cells. Elevated Nile Red staining of acs-3(ft5)
animals can be rescued by expression of acs-3
cDNA with regulatory elements upstream of acs-
3 start site, as well as with the wrt-2 and grd-10
seam-cell-specific promoters (E). Expression in
the body-wall muscle, a tissue in which acs-3 is
not normally expressed, driven by the myo-3
promoter fails to rescue the high Nile Red staining
of acs-3(ft5) animals (F). We quantified Nile Red
intensity in these lines (G). Data are shown as
a percentage of the WT average ±SEM. ***p <
0.001 compared to acs-3(ft5).
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whether either the increased rate of uptake or synthesis
would alter composition of fats, we examined the fatty acid
profile of WT and acs-3(ft5) mutants. There were no signifi-
cant differences in fatty acid profiles between these strains
(Figure 3F).
Together, these data indicated that the altered fat storage of
acs-3(ft5) animals is not a consequence of altered behaviors or
defective fat oxidation, but rather acs-3(ft5) mutants exhibit
a metabolic shift favoring an increased rate of dietary fatty
acid uptake and an elevated rate of de novo fat synthesis,
processes consistent with the lipid storage phenotype of these
animals.402 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc.Loss of Function of Acyl-CoA-
Consuming Enzymes Suppresses
the Effects of acs-3(ft5) Mutation
Seam cells are anatomically distant from
the intestinal lumen, where uptake of die-
tary fatty acid occurs. Moreover, many
genes that encode components of lipid
metabolism are expressed in intestinal
and epidermal cells, while few have thus
far been reported to be expressed in
seam cells (Hunt-Newbury et al., 2007;
Srinivasan et al., 2008). To elucidate
how loss of ACS-3 activity in seam cells
elicits the observed whole-animal meta-
bolic changes, we sought to identify addi-tional genes required for the observed phenotypes of acs-3
(ft5) mutants. To do so, we took advantage of the fortu-
itous observation that treatment of animals with 110 mM of
LY294002, a broad-spectrum inhibitor of phosphatidylinositol
3-kinases (PI3Ks), results in developmental arrest in acs-3(ft5)
yet causes only minor developmental delay of WT animals
(Figure 4A). LY294002 has been reported to functionally inhibit
AGE-1, the sole C. elegans class I PI3K (Babar et al., 1999).
However, we found that growth arrest of drug-treated acs-3
mutants was unlikely to be only due to inhibition of AGE-1, since
acs-3(ft5); age-1(hx546) double mutants did not arrest in the
absence of drug treatment, nor were they sensitive to treatment
with LY294002 (Figure S3). Despite the fact that we did not know
Figure 3. Characterization of Metabolic Parameters Reveals acs-3
(ft5) Animals Have an Increased Rate of Fatty Acid Uptake and
Elevated De Novo Fatty Acid Synthesis
(A–F) We examined a number of physiological parameters that could impact
lipid storage. To assess b oxidation, we incubated animals in media containing
tritiated fatty acids, collected that media, and measured amount of tritiated
water produced (see Experimental Procedures for more details). We found
that acs-3(ft5) animals exhibited an increased rate of b oxidation (A). Measures
of pharyngeal pumping rate and progeny production revealed no differences
between WT and acs-3(ft5) mutants (B and C). To examine fatty acid uptake,
we incubated animals in media containing BODIPY-labeled fatty acids for
20 min, then measured fluorescence intensity. We found that acs-3(ft5)
mutants exhibit more than double the rate of fatty acid uptake observed in
WT animals (D). For (A)–(D), data are displayed as a percentage of the WT
average ±SEM. ***p < 0.001 compared to WT. Using 13C labeling, we found
that acs-3(ft5) mutants exhibit a higher percentage of de novo synthesized
fatty acids (E). **p < 0.01, ***p < 0.001 compared to WT. GC/MS analysis
reveals no substantial changes in fatty acid composition between acs-3(ft5)
mutants and WT animals (F). Data are shown as a percentage of total fatty
acid ±SEM.
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acs-3(ft5)mutants, the striking arrest phenotype provided a facile
screening strategy to search for potential suppressors of acs-3
(ft5). We anticipated that such an approach would be more
specific than screening for suppression of the acs-3(ft5) Nile
Red staining phenotype, as inactivation of many genes is known
to alter Nile Red staining (Ashrafi et al., 2003).
F2 progeny of mutagenized acs-3(ft5) animals were grown on
110 mM LY294002, and animals that developed to adult stage in
72 hr, a time point at which acs-3(ft5) animals are 100% arrestedCellin the L2 or L3 larval stages, were selected (Figure 4A). Newly
identified acs-3(ft5) suppressors were assayed for Nile Red
staining independent of LY294002 treatment. In all cases, high
Nile Red staining of acs-3(ft5) animals was reduced to nearly
WT levels (Figures 4C and 4D), suggesting that the identified
mutations indeed suppressed the effects of acs-3(ft5), at least
on Nile Red staining, rather than simply preventing LY294002
action.
We identified the molecular lesions in ft8, ft11, ft12, and ft14
suppressor lines (Table 1). In ft8 and ft11, we found missense
mutations in the Y45F3A.3 gene, encoding a predicted very-
long-chain acyl-CoA dehydrogenase, which we named acdh-
11. In ft11, we found a missense mutation in the T08G2.3
gene, encoding a predicted medium-chain acyl-CoA dehydro-
genase, which we named acdh-10. Finally, in ft14, we identified
a nonsense mutation in the F41H10.8 gene, encoding the fatty
acid elongase elo-6 (Table 1). Identified mutations in acdh-10,
acdh-11, and elo-6 suppressed acs-3(ft5) in a recessive manner,
indicating they were loss-of-function mutations. The early STOP
in elo-6(ft14) was consistent with a loss of function, and treat-
ment of acs-3(ft5) mutants with two-generation RNAi of either
acdh-10 or acdh-11 suppressed LY294002-induced growth
arrest of these animals in a manner similar to the mutations iden-
tified (data not shown).
A number of observations indicated that loss of acdh-10,
acdh-11, or elo-6 counteracts the phenotypes caused by acs-3
(ft5) reduction of function. First, although the LY294002 induced
growth arrest, high Nile Red staining, enlarged droplet size, and
the high fatty acid uptake rate of acs-3(ft5) animals were either
partially or fully reverted to WT levels by elo-6(ft14), acdh-10
(ft11), and acdh-11(ft8); none of these mutations on their own
caused a detectable change in these parameters when com-
pared to WT animals (Figures 4A–4D and S4). Second, acdh-
10(ft11), acdh-11(ft8), and elo-6(ft14) mutants all developed
and grew at or near WT rates and exhibited normal pharyngeal
pumping rates, further indicating that these mutations do not
correct the altered fat storage of acs-3(ft5) mutants merely due
to detrimental effects on animal viability or changes in food
intake (Figure S5 and data not shown).
To begin elucidating how the newly identified suppressors
counter the effects of loss of acs-3, we first investigated their
expression patterns. In each case, expression of GFP reporter
fusion was first detected during embryonic development and
persisted through larval and adult stages (Figure S5 and data
not shown). As previously reported (Pauli et al., 2006), we found
that elo-6 expression was largely confined to the intestinal cells
and undetectable in the seam cells (Figure S5). Similarly, there
was no detectable acdh-11 expression in the seam cells,
although expression was clearly visible in many other cell types,
including the fat-storing hypodermal and intestinal cells (Fig-
ure S5). Reporter fusion of acdh-10 exhibited a broad expression
in numerous tissues (Figure S5). Thus, reduction of function of
ACS-3 can be ameliorated by deficiencies in metabolic enzymes
in tissues other than the seam cells.
Since elo-6 regulates production of monomethyl branched
fatty acids (mmBCFA) (Kniazeva et al., 2004; Seamen et al.,
2009), we tested whether elo-6(ft14) suppression of acs-3(ft5)
is due to diminished mmBCFA levels. As expected, acs-3(ft5);
elo-6(ft14) double mutants had reduced levels of mmBCFAMetabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc. 403
Figure 4. An Unbiased Mutagenesis Screen
Identifies Two Acyl-CoA Dehydrogenases
and a Fatty Acyl-CoA Elongase as Suppres-
sors of acs-3(ft5) Growth and Fat Storage
Phenotypes
(A–D) acs-3(ft5) animals exhibit a developmen-
tal arrest when treated with the PI3K inhibitor
LY294002. We performed an unbiased mutagen-
esis screen utilizing this phenotype and identified
two alleles of acdh-11, one allele of acdh-10, and
one allele of elo-6 as suppressors of this develop-
mental phenotype (A). These mutations also sup-
pressed the high fatty acid uptake of acs-3(ft5)
mutants but do not affect uptake in an otherwise
WT background (B). The elevated Nile Red stain-
ing phenotype of acs-3(ft5) mutants was also
suppressed by these mutations, while each of
these suppressors, when outcrossed to an other-
wise WT background, exhibited normal Nile Red
staining phenotype (C and D). Data are displayed
as a percentage of the WT average ±SEM.
**p < 0.01, ***p < 0.001 compared to acs-3(ft5).
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fatty acids failed to reverse the elo-6(ft14) suppression of acs-3
(ft5) (Figure S7), suggesting lowmmBCFA levels do not suppress
acs-3(ft5). Additionally, there were no obvious changes in
mmBCFA caused by losses of acdh-10 and acdh-11 (Figure S6).
A unifying explanation for how mutations in each of acdh-10,
acdh-11, and elo-6 restore WT growth and lipid metabolic
phenotypes to acs-3(ft5) mutants is that each of these enzymes
modulates fatty acyl-CoA turnover. As an elongase enzyme,
ELO-6 acts on fatty acyl-CoAs, effectively depleting the fatty
acyl-CoA pool of shorter chain lengths through production of
longer-chain fatty acyl-CoAs, while ACDH enzymes are well
known to function downstream of ACS enzymes in b oxidation
of fatty acyl-CoAs (Eaton et al., 1996). As such, the deficiency
in generation of acyl-CoA products of ACS-3 could be countered
by simultaneous deficiencies in enzymes that consume fatty
acyl-CoAs. Our findings additionally indicate that these enzymes
need not function in the very same tissue.
acs-3 Regulation of Fat Storage and Growth Is
Dependent on the Nuclear Hormone Receptor nhr-25,
a Member of the SF-1 and LRH-1 Family
How might changes in ACS-3-generated acyl-CoA products
in the seam cells cause changes in fatty acid uptake and lipid
storage phenotypes in intestinal cells? In addressing this
question, we were guided by the molecular identity of yet
another suppressor of acs-3(ft5). In the suppressor line ft13,
we identified a missense mutation in Y46E12BL.4, a previously
uncharacterized gene (Table 1). As in the acdh and elo-6 sup-
pressors, the ft13 mutation suppressed both the LY294002-
induced growth arrest and Nile Red staining phenotypes of
acs-3(ft5) mutants without causing obvious changes in growth
and staining patterns of otherwise WT animals (Figure S8).
We generated RNAi constructs targeting Y46E12BL.4 and
found that knockdown of this gene in acs-3(ft5) mutants reca-404 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inpitulated the suppression observed in the mutant background,
confirming the identity of the suppressor mutation (data not
shown).
Y46E12BL.4 encodes an uncharacterized protein predicted to
contain a conserved SPRY domain. The predicted SPRY domain
is closely related to the SPRY domains of the D. melanogaster
protein GUSTAVUS, which has a role in early embryonic devel-
opment, and the mouse Ssb-1, -2, -3, and -4 proteins, whose
physiological functions remain poorly understood. Each of these
homologous proteins contains both a central SPRY domain
as well as a C-terminally encoded SOCS box domain. This
latter domain was lacking from the WormBase prediction of
Y46E12BL.4. We performed 30 RACE to identify the 30 end of
the Y46E12BL.4 cDNA and found that this gene does indeed
encode a protein with both an SPRY and a C-terminal SOCS
box domain. Therefore, we named this gene spsb-1 (SPRY and
SOCS box gene).
Although C. elegans spsb-1 is uncharacterized, and our
attempts at obtaining transgenic animals expressing spsb-1::
GFP fusions were unsuccessful, its homology to GUSTAVUS
provided a potential clue to mechanisms through which acs-3
may exert its effects on metabolism. In a yeast two-hybrid
screen, Drosophila GUSTAVUS was found to interact with
FTZ-F1 (Giot et al., 2003), an NR5ANHR family member (Asahina
et al., 2000). Similar to acs-3, nhr-25, the sole NR5A family
member in C. elegans, is expressed in seam cells. Moreover, in
response to as-yet-unidentified signals, nhr-25 regulates molt-
ing, an endocrine program that is initiated in the seam cells but
exerts effects throughout C. elegans tissues (Asahina et al.,
2000; Frand et al., 2005; Kostrouchova et al., 1998). The fact
that some NHRs are regulated by lipophilic hormones, coupled
with the identities of suppressors of acs-3, suggested that fatty
acyl-CoA product of ACS-3 may directly or indirectly regulate
function of NHR-25 to in turn regulate an endocrine program of
fat uptake and de novo fat synthesis.c.
Figure 5. Mutation of nhr-25 Suppresses the High Nile Red Staining
and Fatty Acid Uptake Phenotypes of acs-3(ft5) Animals
(A–F) The hypomorphic nhr-25(ku217) allele partially suppresses the develop-
mental arrest of acs-3(ft5)mutant animals grown on LY294002 (A). Arrow indi-
cates position of an arrested acs-3(ft5) animal. nhr-25(ku217) also suppresses
the high fatty acid uptake phenotype and high Nile Red staining phenotype of
acs-3(ft5) animals, but nhr-25(ku217), in an otherwiseWT background, exhibits
WT fatty acid uptake and Nile Red staining (B–D). Data are shown as
a percentage of the WT average ±SEM. ***p < 0.001 compared to acs-3(ft5).
We also tested the effect of acs-3(ft5) on previously described nhr-25(ku217)
phenotypes. We found that loss of acs-3 function can partially suppress
both the sterility and egg-laying phenotypes of nhr-25(ku217) (E and F). Data
are shown as a percent of all animals assayed. Because the severity of the
egg-laying and sterility phenotypes in nhr-25(ku217) is temperature depen-
dent, we performed these assays at 24C, a temperature at which these
phenotypes are strong, but most animals develop to adulthood.
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be expressed in the seam cells (identified in a search of http://
www.wormbase.org). We tested whether RNAi-mediated inacti-
vation of any of these genes could either recapitulate the acs-3
(ft5) phenotype or suppress it. Only RNAi knockdown of nhr-
25, but none of other NHRs tested, suppressed the high Nile
Red staining of acs-3(ft5) mutants without altering staining in
WT animals (data not shown). Unambiguous interpretation of
this finding was not possible because of pleiotropic phenotypes
such as sterility, partially penetrant lethality, and reduced body
size (Asahina et al., 2000; Chen et al., 2004) associated with
nhr-25 RNAi treatment. Therefore, we generated acs-3(ft5);
nhr-25(ku217) double mutants. ku217 is a hypomorphic allele
of nhr-25 that exhibits reduced DNA-binding activity, yet retains
enough activity to allow for relatively normal rates and patterns of
development up until the adult stage in a majority of animals, at
which point all animals exhibit a severe defect in egg laying (Chen
et al., 2004). Experiments with this allele were performed before
the onset of the egg-laying-deficient phenotype. Nile Red stain-
ing, large droplet formation, and fatty acid uptake were signifi-
cantly reduced in acs-3(ft5); nhr-25(ku217) double mutants
compared to acs-3(ft5), while nhr-25(ku217) alone exhibited
WT fatty acid uptake, Nile Red staining levels, and lipid droplet
size (Figures 5B–5D and S4). Moreover, nhr-25(ku217) partially
suppressed the growth arrest phenotype of LY294002-treated
acs-3(ft5) animals (Figure 5A). Together, these data suggested
that phenotypes caused by acs-3 reduction of function were
dependent on nhr-25. Consistent with this interpretation, nhr-
25 is expressed in seam cells, the excretory cell, and cells of
the developing vulva (Asahina et al., 2000; Chen et al., 2004;
Gissendanner and Sluder, 2000), a pattern very similar to that
of acs-3 (Figures 2A, 2B, and S1).
To further investigate the genetic interaction between acs-3
and nhr-25, we examined a number of nhr-25-dependent pheno-
types. As previously reported, we found that nhr-25(ku217)
animals exhibit partially penetrant sterility, while fertile animals
that develop to adulthood exhibit a strong egg-laying-defective
phenotype caused by improper vulval development (Chen
et al., 2004). The vulval development defect was partially cor-
rected by the acs-3(ft5)mutation, as was the sterility associated
with loss of nhr-25 function (Figure 5E). nhr-25(ku217) animals
also exhibit extranumerary seam cells; however, this phenotype
was neither suppressed nor enhanced in acs-3(ft5); nhr-25
(ku217) double mutants (data not shown). Together, these find-
ings provide additional evidence supporting a genetic regulatory
relationship between acs-3 and nhr-25, consistent with the
possibility that loss of acs-3(ft5) is associated with enhanced
activity of NHR-25.
The nhr-25 Ligand-Binding Domain Accommodates
Phosphoinositide Lipids Containing Long-Chain
Fatty Acids
nhr-25 is the single C. elegans member of the NR5A family of
NHRs. This family includes D. melanogaster FTZ-F1 and mam-
malian LRH-1 and SF-1. One possible mechanism linking acs-
3 and nhr-25 was suggested by biochemical studies of SF-1
and LRH-1. While the existence and identity of potential ligands
of these mammalian receptors have been debated, these recep-
tors accommodate phospholipids containing long-chain fattyCellacids in their ligand-binding pockets (Krylova et al., 2005; Li
et al., 2005b). In vitro experiments with mammalian SF-1 have
shown that phosphoinositides are efficiently exchanged into
the ligand-binding domain, raising the possibility that these lipids
may act as ligands for these receptors (Krylova et al., 2005;
Sablin et al., 2009).
To investigate potential biochemical similarities between
mammalian and C. elegans NR5A class of receptors, we gener-
ated purified recombinant NHR-25 ligand-binding domain pro-
tein. Utilizing a previously described assay (Sablin et al., 2009),
we tested the ability of this purified protein to incorporate
phospholipids in vitro. We found that as in the mammalian
NR5A ligand-binding domains (Krylova et al., 2005), NHR-25Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc. 405
Figure 6. NHR-25 Ligand-Binding Domain Binds Phosphoinositides
(A and B) Mammalian SF-1, an nhr-25 homolog, has been shown to bind phos-
phoinositide species. To test the ability of NHR-25 to bind these lipids, we
generated and purified recombinant NHR-25 ligand-binding domain. Incuba-
tion of this protein with PI(4,5)P and PI(3,4,5)P alters retention of the protein
in ion-exchange chromatography (A), indicating the protein has bound the
lipid. Incubation of each phosphoinositide species with NHR-25 ligand-
binding domain protein induced 50% of the protein to bind lipid (B).
Cell Metabolism
acs-3 and nhr-25 Regulate C. elegans Lipid Storageligand-binding domain could indeed accommodate PI(3,4,5)P3
and PI(4,5)P2 (Figures 6A and 6B).
The ability of purified NHR-25 to bind PI(3,4,5)P3 and PI(4,5)P2
along with the observation that acs-3(ft5) mutants exhibit
a synthetic growth arrested when treated with the PI3K inhibitor
LY294002 suggest the possibility that phosphoinositides may
act as endogenous regulators of nhr-25. Since attachment
of fatty acids to the inositol sugar is dependent on availability
of fatty acyl-CoAs, our findings are consistent with a model
whereby ACS-3 exerts control over NHR-25 activity by deter-
mining the chain lengths of fatty acids present on these rings.
DISCUSSION
We found that animals deficient in acs-3, encoding an ACS that
preferentially produces LCFA-CoA species, exhibited increased406 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Infat uptake, increased de novo fatty acid synthesis, and altered fat
storage, including formation of large lipid droplets. Reconstitu-
tion of acs-3 in the seam cells alone was sufficient to correct
the fat storage phenotypes associated with loss of acs-3. Since
seam cells are a cellular component of C. elegans epidermis that
are not directly involved in dietary fat uptake and de novo fat
synthesis, our findings indicated that ACS-3 activity modulates
organismal fat metabolism through signals that initiate in the
seam cells but ultimately act in other tissues. Consistent with
this hypothesis, we found that the metabolic consequences of
acs-3 loss require nhr-25, a seam-cell-expressed NHR previ-
ously implicated in the regulation of molting, an endocrine
process that links nutrient availability and developmental timing.
Our genetic suppressor analyses and biochemical characteriza-
tion of purified NHR-25 are consistent with amodel whereby loss
of long-chain acyl-CoAs generated by ACS-3 results in aberrant
function of NHR-25, which in turn regulates an endocrine
signaling cascade that ultimately modulates dietary fat uptake
and de novo fat synthesis.
The abnormally large lipid droplets in acs-3(ft5) intestinal cells,
which can be suppressed bymutations in acdh-10, acdh-11, elo-
6, or nhr-25, are reminiscent of those recently described in
animals deficient in peroxisomal b oxidation (Zhang et al.,
2010). As has been shown for the peroxisomal mutants, the
acs-3(ft5) mutant large droplets stain with BODIPY-labeled fatty
acids and are ringed by ATGL::GFP transgenically expressed
in intestinal cells. We found that these large droplets stain with
Nile Red with an emission peak intensity of 570–580 nm, indi-
cating that these large droplets are primarily comprised of
neutral lipids. These findings underscore the utility of Nile Red
staining as an assay to investigate properties of different lipid
storage compartments in intact animals.
It was already known that SF-1 and nhr-25 are both required
for gonadal development and fertility, while both nhr-25 and
LRH-1 are necessary for embryonic development (Asahina
et al., 2000; Fayard et al., 2004; Hammer and Ingraham, 1999).
Our findings indicate that the elevated fatty acid uptake of
acs-3 mutants is nhr-25 dependent. Similarly, LRH-1 regulates
bile acid production and is required for efficient intestinal uptake
of dietary lipids (Mataki et al., 2007). Finally, beyond its well-
recognized role in sex determination, mammalian SF-1 functions
in energy balance as a key transcriptional regulator of glucocor-
ticoid synthesis in the adrenal glands (Bakke et al., 2001). Thus,
in C. elegans as in mammals, an NR5A family receptor modu-
lates metabolic-related pathways.
Onemodel consistent with our findings is that ACS-3 functions
to generate PI(3,4,5)P3 and PI(4,5)P2 species that contain long-
chain fatty acids, which in turn act as inhibitory ligands for
NHR-25. Crystallographic studies with recombinant mammalian
SF-1 and LRH-1 have identified bacterial phospholipids as fortu-
itous ligands bound within the ligand pocket of these receptors
(Krylova et al., 2005; Li et al., 2005b). A number of other phos-
pholipids can also be accommodated by the ligand pocket of
these receptors (Krylova et al., 2005; Li et al., 2005b; Sablin
et al., 2009). Among these, phosphoinositides PI(3,4,5)P3 and
PI(3,5)P2 readily bound the ligand-binding domain, and muta-
tions interfering with phosphoinositide binding were found to
reduce transcriptional activity of SF-1 (Krylova et al., 2005;
Sablin et al., 2009). We found that NHR-25 could bind PI(3,4,5)c.
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ments with mammalian SF-1 and LRH-1 (Sablin et al., 2009).
Moreover, sensitivity of acs-3 mutants to the PI3K inhibitor
LY294002 indicated an in vivo regulatory relationship between
phosphoinositides and nhr-25.
Since mammalian NR5A receptors exhibit constitutive activity
in many cell types (Fayard et al., 2004), physiological ligands of
these receptors may function to inhibit activity or modulate
activity specifically toward subsets of transcriptional targets.
Given the preference of ACS-3 for long-chain fatty acids, it is
possible that its reduction of function may preferentially diminish
production of PI(3,4,5)P3 and PI(4,5)P2 species containing long-
chain fatty acids. Our genetic data suggest that such species
normally act to inhibit activity of NHR-25 toward mechanisms
that promote dietary fat uptake and de novo fat synthesis.
Consistent with the notion that chain lengths of fatty acids
present on various lipid species could modulate activity of
NR5A class of receptors, there is evidence that phospholipids
with medium-chain fatty acids enhance in vitro binding of puri-
fied SF-1 to a short peptide motif derived from the TIF-2 coacti-
vactor, while phospholipids containing long-chain fatty acids
competitively disrupt this binding (Li et al., 2005b). However,
since acyl-CoAs are substrates for generation of a variety of
complex lipid species, we cannot rule out the possibility that
ACS-3-derived long-chain fatty acyl-CoAs could exert their
effects on NHR-25 throughmechanisms other than phosphoino-
sitides. Similarly, ACS-3-derived fatty acyl-CoAs may exert their
effects on NHR-25 through modulation of potential coactivators
of NHR-25 or upstream regulatory proteins.
Identification of in vivo physiological lipid ligands of NHRs has
been a fundamental challenge in understanding these complex
transcriptional master regulators. Such ligands may be present
at very low levels and may only associate with NHRs under
specific physiological conditions, making ligand identification
very challenging. Our studies point to ACS enzymes as a previ-
ously unappreciated in vivo mechanism for regulating the func-
tion of the NR5A family of NHRs. Though in vitro experiments
have demonstrated that phospholipids can bind and modulate
activity of the NR5A family nuclear receptor SF-1, our data repre-
sent an in vivo demonstration that genes acting in lipid metabo-
lism function upstream of this family of receptors.EXPERIMENTAL PROCEDURES
Vital Dye Lipid Staining and Quantification
Synchronized animals were plated on NGM plates containing OP50 and 50 nM
Nile Red dye. All lipid-staining experiments were conducted at 25C, as acs-3
(ft5) animals exhibited the strongest phenotype at this temperature. Animals
were grown for 40 hr to the young adult stage. Imageswere acquired on a Zeiss
Axioplan II microscope outfitted with a digital CCD camera. Images shown
were obtained using a 163 objective. For quantification, images were
collected using a 53 objective. The same circular region of interest (ROI)
that encompasses one entire animal was applied to each of these images.
The minimum fluorescence value was subtracted from the mean of the ROI
to correct for background signal. For each experiment, 8–12 animals of each
strain were imaged and analyzed.
For BODIPY staining, a 1 mg/ml stock of C1-BODIPY 500/512 C12
(Invitrogen) was added to NGM plates seeded with OP50 at a final dilution of
1:50,000. Imageswere acquiredwith a 163objective asdescribed forNileRed.
For high Nile Red staining, synchronized L4 animals were plated on seeded
NGM plates containing 5 mM Nile Red (1003) and allowed to stain for 2–4 hr.CellSpectral data were collected on a Nikon C1si spectral confocal scope utilizing
a 488 nm laser for excitation and collecting emitted light at 5 nm intervals from
500 to 660 nm.
In Vitro Assay of ACS Function
The acs-3 cDNA was cloned into the bacterial expression vector pBAD-
DEST49 (Invitrogen), allowing for L-arabinose-inducible expression of the
ACS-3 protein with an N-terminal thioredoxin tag to improve solubility and
a C-terminal 63 His tag. This construct was expressed from E. coli and puri-
fied with nickel resin. ACS activity was assayed using an enzyme-coupled
colorimetric assay modified for use in 96-well format (Knoll et al., 1994).
ACS activity generates acyl-CoA species from free fatty acid and CoA.
Bacterial acyl-CoA oxidase in the reaction mix acts on acyl-CoA, generating
H2O2. Catalase in the assay solution produces formaldehyde from H2O2
and methanol. Formaldehyde reacts with 4-amino-3-hydrazino-5-mercapto-
1,2,4-triazole and IO4
 to generate a purple dye that can be detected at
550 nm. We empirically determined the absorption coefficient of the resulting
dye to be 33 107 M1 0.5 cm1 and used this to calculate the amount of fatty
acyl-CoA produced in each experiment. We generated a standard curve and
verified that absorption at 550 nm is linear, with acyl-CoA concentration
within the range tested. Commercially available Pseudomonas ACS protein
(Sigma) was used as a positive control. All control assays were performed
three times, while experimental assays using ACS-3 protein were performed
five times.
Generation of Transgenic Animals
To assess the expression pattern of acs-3, 2.5 kb of the upstream regulatory
sequence of T08B1.6 was amplified by PCR and fused to GFP unc-54 30
UTR. This product was injected into N2 adults at 5 ng/ml with a rol-6 coinjection
marker to generate strain KQ341. To examine localization of the ATGL protein,
we cloned the C05D11.7a cDNA into a Gateway donor vector (Invitrogen). This
was recombined with the vha-6 promoter into a Gateway destination vector
containing GFP and the unc-54 30 UTR for intestinal expression. This construct
was injected into acs-3(ft5) mutant animals at 5 ng/ml with Ptph-1::GFP as
a coinjection marker to generate strain KQ1982. To rescue acs-3(ft5) and
determine subcellular localization of the ACS-3 protein, 2.5 kb of the upstream
regulatory sequence was cloned into a Gateway donor vector, recombined
with the T08B1.6 cDNA (Open Biosystems; Huntsville, AL) into a Gateway
destination vector containing GFP and the unc-54 30 UTR, and injected into
acs-3(ft5) adults at a concentration of 3 ng/ml with Podr-1::RFP (gift of C. Barg-
mann) as a coinjection marker to generate strain KQ519. To determine subcel-
lular localization of the mutant ACS-3 protein, the ft5mutation was introduced
by site-directed mutagenesis into the T08B1.6 cDNA Gateway donor vector,
which was recombined with the donor vector containing 2.5 kb of T08B1.6
upstream regulatory sequence into a GFP destination and injected into N2
animals at a concentration of 2 ng/ml with a Pmyo-2::mCherry coinjection
marker to generate strain KQ1332. For seam cell rescue, 1.4 kb of upstream
regulatory sequence from wrt-2 (Open Biosystems) or 0.9 kb upstream regu-
latory sequence of grd-10 was recombined with the T08B1.6 cDNA into
a GFP destination vector and injected at 5 ng/ml with Podr-1::RFP coinjection
marker into acs-3(ft5) to generate lines KQ579 (wrt-2) and KQ577 (grd-10). For
body-wall-specific expression, 2 kb of myo-3 upstream regulatory sequence
(Open Biosystems) was recombined with T08B1.6 cDNA into a GFP destina-
tion vector and injected at 5 ng/ml with a Pmyo-2::mCherry coinjection marker
into acs-3(ft5) animals to generate line KQ1260. For intestine-specific expres-
sion, 2 kb of elt-2 upstream regulatory sequence (Open Biosystems) was
recombined with the T08B1.6 cDNA into a GFP destination vector and injected
at 5 ng/ml with a Pmyo-2::mCherry coinjection marker into acs-3(ft5) animals to
generate line KQ1335. To examine potential mitochondrial localization of
ACS-3, we generated a construct driving the mitochondrial protein clk-1
(Open Biosystems) with the wrt-2 seam cell promoter and fused to mCherry.
This construct was injected into acs-3(ft5) mutant animals at 5 ng/ml with
Ptph-1::GFP as a coinjection marker to generate line KQ795. To examine
potential colocalization, this line was crossed with line KQ579, carrying
Pwrt-2::acs-3::GFP. To confirm acs-3 is expressed in seam cells, we gener-
ated a Pacs-3::mCherry promoter fusion construct utilizing 2.5 kb of acs-3 50
regulatory sequence and injected this into strain JR667, which carries an
integrated SCM::GFP marker.Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier Inc. 407
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We developed an assay similar to that reported by Spanier et al. (2009).
Synchronized L1 animals were plated on NGM plates seeded with OP50 and
grown at 25C to the young adult stage. The pellet from a saturated OP50
culture was resuspended in an equal volume of S-Basal medium to generate
assay solution. To this solution, 0.75 ml of a 1 mg/ml stock solution of C1-BOD-
IPY 500/512 C12 in DMSO was added per milliliter. Animals were washed off
the plates and rinsed 23 in S-Basal medium. After the final rinse, animals were
allowed to settle to the bottom of a 15ml conical tube, then 30 ml containing the
settled animals was removed from the conical tube, and added to 0.5 ml assay
solution in a foil-wrapped 1.5 ml tube. The animals were incubated at room
temperature for 20 min while rotating. Following incubation, animals were
allowed to settle to the bottom of the tube for 1 min, then pipeted onto a slide
containing an agar pad and prechilled on a cold aluminum block. For quantifi-
cation of uptake, images were collected using a 53 objective. The same
circular ROI that encompasses one entire animal was applied to each of these
images. Theminimum fluorescence valuewas subtracted from themean of the
ROI to correct for background signal. For each experiment, 8–12 animals of
each strain were imaged and analyzed.Measurement of De Novo Fatty Acid Synthesis and Fatty
Acid Composition
Metabolic labeling was performed essentially as described (Perez and Van
Gilst, 2008). Briefly, equal amounts of bacteria grown in either LB (12C media)
or isogro (98.5% 13C-enriched Sigma) were mixed and plated onto agarose
plates. For each sample, 30,000 synchronized L1 animals prepared from
bleaching gravid adults were added to these plates and grown for 44–48 hr
at 20C. Lipids were extracted and fatty acids analyzed as described (Perez
and Van Gilst, 2008).Fatty Acid Oxidation Assay
Synchronized L4 animals were washed off plates with 0.9% NaCl, then
rinsed three times in 0.9% NaCl. Following washes, animals were incubated
for 20 min in 0.9% NaCl to allow animals to empty their intestines and then
resuspended in S-Basal in a final volume of 540 ml. An aliquot (20 ml) was
stored at 80C for subsequent protein determination. [9,10(n)-3H]Oleic
acid (GE Healthcare) was added to worms to a final concentration of
20 mM (specific activity 67–93 Ci/mol), complexed to fatty-acid-free BSA in
a 2:1 molar ratio. Samples were incubated on an orbital shaker for 1 hr at
20C. Subsequently, TCA was added to a final concentration of 5% w/v.
After mixing, samples were centrifuged (140003 g, 10 min), and the
supernatant (1 ml) was transferred to a new microcentrifuge tube. Phos-
phate-buffered saline (250 ml) and 5 M NaOH (100 ml) were added prior to
ion-exchange chromatography on Dowex 1 3 8 (200–400 MESH) ion-
exchange columns (1 ml). Samples were eluted using water (1 ml), and the
amount of 3H2O in the eluate was determined by scintillation counting.
Samples without animals were included as background controls. Addition
of NaN3 (10 mM) to WT animals inhibited fatty acid oxidation to approxi-
mately 10%. In addition, feeding animals with fadR bacteria, a strain inca-
pable of taking up fatty acids, did not affect labeled water production,
demonstrating that bacterial fatty acid oxidation does not contribute signifi-
cantly to measured rates (data not shown).acs-3(ft5) Suppressor Screen
Synchronized L4 acs-3(ft5) animals were mutagenized with 47 mM EMS (ethyl
methanesulfonate) essentially as described (Brenner, 1974). Mutagenized
animals were rinsed and plated on NGM plates containing OP50. After 24 hr,
animals were collected and bleached to obtain F1 embryos. These animals
were incubated overnight in S-Basal medium to synchronize the population,
split into ten pools, and plated on NGM plates with OP50. Forty thousand F1
animals were collected 72 hr later, and their embryos were collected by bleach
treatment. F2 animals were synchronized overnight in S-Basal, then plated at
a high density on 10 cm plates containing 110 mMLY294002 and OP50. Plates
were screened 72–96 hr later, and animals that had reached the gravid adult
stage were picked. These lines were rescreened, yielding seven lines exhibit-
ing moderate to strong suppression.408 Cell Metabolism 12, 398–410, October 6, 2010 ª2010 Elsevier InNHR-25 LBD Protein Purification and Ligand Exchange
The 6XHIS-NHR-25 LBD (amino acids 309–541 of the NHR-25a spliceform)
was cloned into pBH4 bacterial expression vector, expressed in DE3 pLysS
E. coli, purified by Ni-Trap affinity purification followed by Q-ion-exchange
chromatography, and size excluded into 20 mM HEPES (pH 8.0) with 1 mM
EDTA, essentially as previously described for NR5A receptors (Krylova et al.,
2005; Sablin et al., 2009). Di-palmitoyl (C16) PI(4,5)P2 and PI(3,4,5)P3 (Cayman
Chemical Co.; Ann Arbor, MI) were solubilized in water, then immediately
added from a Hamilton syringe to a solution of purified NHR-25 LBD (10 mM
final) at a 5-fold molar excess of PIP (50 mM final) in borosilicate glass tubes.
Incorporation of PIPs into NHR-25 LBD was allowed to reach equilibrium while
nutating at room temperature for 16 hr under nitrogen, essentially as previously
described for mSF-1 LBD (Sablin et al., 2009). Following determination of the
elution profile of NHR-25 LBD alone, the apo-NHR-25 LBD and NHR-25
LBD:PIP species were separated by MonoQ ion-exchange chromatography.
Peaks were integrated by AKTA FPLC Unicorn 5.1 software, and the
percentage of PIP incorporation was calculated by dividing the integrated
PIP-incorporated peak by the total area under all NHR-25 LBD peaks.SUPPLEMENTAL INFORMATION
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